Matches in Nanopublications for { ?s ?p "[Variants identified through this study were previously reported to be involved in FTD and/or MND, but we are the first to describe their effects as potential disease modifiers in the presence of a clear pathogenic mutation (i.e.C9ORF72 repeat expansion).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP1222097.RAUhXqtff8Y6yOzdd3nWPVwBPvKzxbl7A2X8_Drf8atCU130_assertion description "[Variants identified through this study were previously reported to be involved in FTD and/or MND, but we are the first to describe their effects as potential disease modifiers in the presence of a clear pathogenic mutation (i.e.C9ORF72 repeat expansion).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1222097.RAUhXqtff8Y6yOzdd3nWPVwBPvKzxbl7A2X8_Drf8atCU130_provenance.
- NP1222098.RAfbe5FqZIl3dJKLSByMSGfHt5DbbxZ0BtG5qam802JyA130_assertion description "[Variants identified through this study were previously reported to be involved in FTD and/or MND, but we are the first to describe their effects as potential disease modifiers in the presence of a clear pathogenic mutation (i.e.C9ORF72 repeat expansion).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1222098.RAfbe5FqZIl3dJKLSByMSGfHt5DbbxZ0BtG5qam802JyA130_provenance.
- assertion description "[Variants identified through this study were previously reported to be involved in FTD and/or MND, but we are the first to describe their effects as potential disease modifiers in the presence of a clear pathogenic mutation (i.e.C9ORF72 repeat expansion).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Variants identified through this study were previously reported to be involved in FTD and/or MND, but we are the first to describe their effects as potential disease modifiers in the presence of a clear pathogenic mutation (i.e.C9ORF72 repeat expansion).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1222099.RAmIQJsuHZp_I7PJzUnFWBh-D0Pbyu8rAERHfrED-OalE130_assertion description "[Variants identified through this study were previously reported to be involved in FTD and/or MND, but we are the first to describe their effects as potential disease modifiers in the presence of a clear pathogenic mutation (i.e.C9ORF72 repeat expansion).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1222099.RAmIQJsuHZp_I7PJzUnFWBh-D0Pbyu8rAERHfrED-OalE130_provenance.